Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zheng-liang Ma
Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model
Anesthesiology
Anesthesiology
Pain Medicine
Related publications
Metabotropic Glutamate Receptor Subtype 4 (mGluR4)
Science-Business eXchange
Metabotropic Glutamate Receptor 5 Knockout Reduces Cognitive Impairment and Pathogenesis in a Mouse Model of Alzheimer's Disease
Molecular Brain
Molecular Neuroscience
Molecular Biology
Cellular
Differences in Agonist and Antagonist Activities for Two Indices of Metabotropic Glutamate Receptor-Stimulated Phosphoinositide Turnover
British Journal of Pharmacology
Pharmacology
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain
Journal of Pain
Neurology
Anesthesiology
Pain Medicine
The Metabotropic Glutamate Receptor Subtype 5 Mediates Sensitivity to the Sedative Properties of Ethanol
Pharmacogenetics and Genomics
Molecular Medicine
Genetics
Molecular Biology
Selective Potentiation of the Metabotropic Glutamate Receptor Subtype 2 Blocks Phencyclidine-Induced Hyperlocomotion and Brain Activation
Neuroscience
Neuroscience
Effects of Metabotropic Glutamate Receptor Activation in Auditory Thalamus
Journal of Neurophysiology
Neuroscience
Physiology
PPAR Antagonist Attenuates Mouse Immune-Mediated Bone Marrow Failure by Inhibition of T Cell Function
Haematologica
Hematology
Cannabinoid Receptor 2‑selective Agonist JWH015 Attenuates Bone Cancer Pain Through the Amelioration of Impaired Autophagy Flux Induced by Inflammatory Mediators in the Spinal Cord
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
